STABLE LIPOSOMAL NEBULIZING INHALATION FORMULATIONS FOR CONTROLLED PULMONARY DELIVERY SYSTEMS

摘要

The present invention disclosed a stable liposomal nebulizing inhalation formulation of salbutamol sulphate for use in the treatment of asthma to give controlled drug delivery for pulmonary systems. This invention is more particularly relates to liposomal carriers in the form of nebulizing inhalation formulations that can carry the drug into deep lung and maintain it at the site of action for a prolonged therapeutic effect. Drawing 02 Sheets. Total Pages: 37 (FIG.- NIL)